Low Phytanic Acid-Concentrated DHA Prevents Cognitive Deficit and Regulates Alzheimer Disease Mediators in an ApoE(−/−) Mice Experimental Model

Alzheimer’s disease (AD) is the main cause of dementia and cognitive impairment. It has been associated with a significant diminution of omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) levels in the brain. Clinical trials with DHA as a treatment in neurological diseases have shown inco...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-Roso, María Belén, Echeverry-Alzate, Víctor, Ruiz-Roso, Baltasar, Quintela, José Carlos, Ballesteros, Sandra, Lahera, Vicente, de las Heras, Natalia, López-Moreno, José Antonio, Martín-Fernández, Beatriz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356727/
https://www.ncbi.nlm.nih.gov/pubmed/30577526
http://dx.doi.org/10.3390/nu11010011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356727/
https://www.ncbi.nlm.nih.gov/pubmed/30577526
http://dx.doi.org/10.3390/nu11010011

Ejemplares similares